Pacific Biosciences of California, Inc. Accrued Liabilities, Current
Pacific Biosciences of California, Inc. (PACB) had Accrued Liabilities, Current of $30.32 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $30.32M.
- 2026-03-31: Accrued Liabilities, Current $33.90M.
- 2025-12-31: Accrued Liabilities, Current $33.65M.
- 2025-09-30: Accrued Liabilities, Current $29.17M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $30.32M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $33.90M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $33.65M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $29.17M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $26.54M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $29.34M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $22.59M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $19.18M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $22.46M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $21.99M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $45.71M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $34.66M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $27.01M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $19.38M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $32.60M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $24.89M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $25.17M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $19.49M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $36.26M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $30.82M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $22.91M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $14.67M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $17.35M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $15.08M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $12.20M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $17.96M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $13.24M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $15.82M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $14.11M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $11.16M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $12.82M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $9.30M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $10.94M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $10.24M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $12.62M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $11.23M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $17.84M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $17.25M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $16.60M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $16.48M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $16.33M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $12.20M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $15.55M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $11.34M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $11.32M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $9.44M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $11.44M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $8.73M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $9.22M 10-Q · filed 2014-08-05 | |
| 2013-12-31 | $7.91M 10-K · filed 2015-03-12 | $8.77M 10-Q · filed 2014-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |